| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.8 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0091 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.03 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |